• AbbVie's blockbuster drug Skyrizi gets FDA nod for treating Crohn's disease

    7 days ago - By MedCity News

    AbbVie drug Skyrizi is now approved for Crohn's disease, making it the first treatment for the disorder that addresses a particular protein associated with inflammation. In other drug decision news, the Rhythm Pharmaceuticals product Imcivree added the rare disease Bardet-Beidl syndrome as a new approved indication.
    Read more ...